ELOX · Eloxx Pharmaceuticals, Inc. · Executive Compensation
$13.30
+0.08 (+0.61%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 11, 2026
The latest filing no longer states the doubt (first flagged May 5, 2026).
View the 10-Q filed Aug 11, 2026Market Cap
$53.68M
Shares
4.04M
Volume · Oct 21
16.28K
Avg daily vol (3M)
43.03K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Nina Kjellson | director | Appointed | 2026-06-01 |
| Stephen W. Webster | director | Appointed | 2026-06-01 |
| Lindsay Androski | Board | Resigned | 2025-08-12 |
| Tomer Kariv | Board of Directors | Resigned | 2023-12-28 |
| Tomer Kariv | Chairman of the Board | Resigned | 2023-12-28 |
| Dr. Vijay Modur | Head of Research and Development | Resigned | 2023-09-15 |
| Gadi Veinrib | director | Resigned | 2022-07-05 |
| Lindsay Androski | director | Appointed | 2022-07-05 |
| Rajesh Parekh | director | Resigned | 2022-07-05 |
| Zafrira Avnur | director | Resigned | 2022-07-05 |
| Jasbir Seehra | director | Resigned | 2022-07-05 |
| Ran Nussbaum | director | Resigned | 2022-07-05 |
Leadership
- Sumit Aggarwal CEO, Board Member
- Daniel Geffken CFO, Chief Accounting Officer
- Gary D. Rakers CFO
- Neil S. Belloff COO
- Alan Walts Board Member
- Alan Walts, Ph.D. Board Member
- Lindsay Androski Board Member
- Nina Kjellson Board Member
- Raj Parekh Board Member
- Raj Parekh, Ph.D. Board Member
- Stephen W. Webster Board Member
- Steve Rubin Board Member